Gene therapy maker bluebird to go private in discounted deal amid cash crunch Gene therapy maker bluebird bio on Friday agreed to be taken private by Carlyle Group and SK Capital Partners at a ...
HALIFAX, England-- ( BUSINESS WIRE )--Funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the specialty materials, ingredients, and life sciences sectors, ...